03:38 PM EST - Lorus Therapeutics Inc. : reported financial results for the three months ended February 28, 2011. Net loss for the quarter increased to $1.6 million ($0.10 per share) compared to $1.3 million ($0.14 per share) in the same period in the prior year. Research and development expenses totaled $760,000 in the three-month period ended February 28, 2011 compared to $718,000 during the same period in the prior year. Lorus Therapeutics Inc.
shares T.LOR are trading down $0.06 at $0.77.
